We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How the Industrial Emissions Best Available Technique (BAT) regime works from the end of the transition period.
Kyowa Kirin Limited has notified MHRA that the priming instructions in the current PIL for Tostran 2% gel require updating.
The epidemiology, symptoms, diagnosis and management of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2).
Events courses and programmes to develop skills, knowledge and networks for chief executive officers, deputy-CEOs and their equivalents in public service.
Guidance for manufacturers, importers and distributors.
The MHRA has authorised cabotegravir as 30 mg tablets and as a 600 mg long-acting injection administered every two months
BAT for diesel engines on an installation that are classed as new medium combustion plant, operating up to 500 hours a year that are exempt from emission limit values (ELVs).
The International Tech Hub Network (ITHN) works to forge innovation partnerships between the UK and international tech sectors, stimulate local digital economies, and build high-end digital skills to drive sustainable jobs and growth.
The Fund aims to create the opportunity to build strong partnerships between UK and Turkish scientists, researchers and institutions.
Delivery of substantial industry placements in return for industry placement capacity and delivery fund (CDF) in 2018 to 2019.
Dstl ensures the UK can develop and exploit new sensor technologies for our defence and security, to find and assess potential threats and give information to decision-makers.
This playbook explains how we use social media at GDS. In it, we share our best practice, what we've learned and what we're planning to do.
Find out about our Export Development Guarantee: its benefits, eligibility criteria and how to apply.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Dstl ensures the UK armed forces have the required weapons capability through research, development and demonstration of advances in science and technology.
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
Substances that are classed as persistent organic pollutants (POPs) and when you're allowed to use them.
The MHRA will introduce a patient alert card to increase awareness among men taking finasteride about potential psychiatric and sexual side effects
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.